AGP Executive Report
Last update: 6 hours agoBiotech: Swiss drugmaker Idorsia says the FDA granted breakthrough status to daridorexant for insomnia in 10- to 17-year-olds, a group with no FDA-approved drug treatments. Life Sciences Industry: Lonza is buying five US manufacturing sites from Merck KGaA, expanding its production footprint and deepening its contract drug-manufacturing business. Robotics: ETH Zurich has developed a flexible drone designed to withstand collisions. AI: Proton CEO Andy Yen says the company expects AI to handle most coding and plans to stop hiring software engineers after 2026. Space Science: A Swiss satellite is set to improve forecasts of solar storms, which can disrupt satellites and communications.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.